NCT03206840

Brief Summary

Despite the increasing popularity of mindfulness meditation and hypnosis in healthcare and in the general community the underlying neurobiological mechanisms are unclear. The change in the relationship between the self and the conscious experience that they bring about may be crucial. This study aims to identify the neural correlates of self-consciousness in meta-awareness and absorption - using functional Magnetic Resonance Imaging (fMRI) in healthy participants combined with detailed first-person experiential accounts and behavioural tasks. This study will provide important clues about the widely reported effects of mindfulness meditation and hypnosis and shed light on the neural correlates of the conscious experience of self.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P75+ for not_applicable healthy-volunteers

Timeline
Completed

Started Oct 2017

Typical duration for not_applicable healthy-volunteers

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 30, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 2, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

October 26, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 12, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 12, 2018

Completed
Last Updated

November 21, 2025

Status Verified

November 1, 2025

Enrollment Period

1 year

First QC Date

June 30, 2017

Last Update Submit

November 18, 2025

Conditions

Keywords

mindfulness meditationhypnosismeta-awarenessabsorptionconsciousnessself

Outcome Measures

Primary Outcomes (2)

  • Reaction time (minutes)

    reaction times during behavioural tasks.

    at day 1

  • Brain activation with IRM

    Activation of different brain areas, as measured with functional Magnetic Resonance

    At day 3

Secondary Outcomes (4)

  • personality trait with questionnaires

    at day 2

  • Scores during behavioural tasks

    at day 1

  • Scores during behavioural tasks

    at day 3

  • salivary volume (millimeter)

    at day 1

Study Arms (2)

Group 1

EXPERIMENTAL

three instructions will be given to each participant: "control", "meditation", "hypnosis". The order of "meditation" and "hypnosis" will be randomized amongst two groups to avoid order effects.

Behavioral: "control", "meditation", "hypnosis".

Group 2

EXPERIMENTAL

three instructions will be given to each participant: "control", "meditation", "hypnosis". The order of "meditation" and "hypnosis" will be randomized amongst two groups to avoid order effects.

Behavioral: "control", "meditation", "hypnosis".

Interventions

three instructions will be given to each participant: "control", "meditation", "hypnosis". The order of "meditation" and "hypnosis" will be randomized amongst two groups to avoid order effects.

Group 1Group 2

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged 18-70
  • Body mass index between 18.5 and 30
  • Covered by health insurance
  • motivated to participate
  • signed informed consent
  • normal or corrected-to-normal eyesight
  • sufficient command of French to be able to follow the instructions

You may not qualify if:

  • history of neurological or psychiatric conditions
  • chronic pain or another medical condition altering pain perception
  • use of medication that affects the central nervous system
  • use of opioids or antidepressant medication
  • severe auditory loss
  • consumption of alcohol or intoxicants on the day of the experiments and the day preceding the experiments
  • pregnancy, breastfeeding or having given birth \<6months ago
  • any contra-indication to Magnetic Resonance Imaging (metal implants or foreign bodies), agitation, claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon Hôpital le Vinatier/Inserm

Bron, 69500, France

Location

Related Publications (1)

  • Lutz A. Regulation of attention and emotions by meditation: neurophysiological basis and implications for mental and physical health. In: 12th BIAL Foundation Symposium "Amplified states of consciousness"; 2018 Apr 6; Porto, Portugal. Lutz A. Méditation, hypnose… se soigner par la conscience. In: INSERM - Culture scientifique (webinar); 2022 Dec 13; Paris, France (online). Lutz A. Mindfulness meditation from the lenses of phenomenology and neurosciences. In: USC Center for Mindful Science - Invited lecture; 2022 Dec 12; Los Angeles (CA), USA. Lutz A. Neurophenomenology after Varela (1996). In: Metanoia/Ouroboros - Seminar; 2021 Sep 1; (online).

    RESULT

MeSH Terms

Interventions

MeditationHypnosis

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesRelaxation TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Antoine LUTZ, PhD

    Lyon Neuroscience Research Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 30, 2017

First Posted

July 2, 2017

Study Start

October 26, 2017

Primary Completion

November 12, 2018

Study Completion

November 12, 2018

Last Updated

November 21, 2025

Record last verified: 2025-11

Locations